NINDS and the National Institute of Allergy and Infectious Diseases (NIAID) request applications to participate in the HLA Region Genomics in Immune-Mediated Diseases Consortium.
The consortium is a cooperative research group whose goals are to define and catalog the association between variations in human leukocyte antigen (HLA) and natural killer cell immunoglobulin-like receptor (KIR) genetic regions and immune-mediated diseases, including risk and severity of disease, and organ, tissue, and cell transplantation outcomes. Identifying and defining the role of specific HLA-region and KIR-region gene variations in disease susceptibility or protection, progression, and severity will allow clinicians to predict disease risk and to develop targeted treatments and/or preemptive strategies.
Application Receipt Date: November 19, 2009
Potential applicants should contact Dr. Ursula Utz, program director, Neural Environment Cluster, NINDS; telephone: 301-496-1431; email: email@example.com. For more information visit http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-09-030.html.